No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Established in Tainan City, Taiwan, in 2001, Sunmax Biotechnology Co., Ltd. functions as a biomedical enterprise. The company specializes in the development, manufacturing, and commercialization of collagen-based medical devices across Taiwan and mainland China. Its diverse product line encompasses Porcogen, a sterile, purified collagen solution valuable for medical device applications, tissue engineering, and research. Sunmax also supplies various dermal fillers, including the Sunmax collagen implant series (I-Plus, I) and FACIALGAIN collagen implants (with and without lidocaine), engineered for correcting facial aesthetic concerns such as wrinkles. For dental procedures, they provide specialized collagen-based solutions like Sunmax collagen dental bone grafts, membranes, and granules, used for augmenting or reconstructing the alveolar ridge, extraction sockets, and in periodontics. Additionally, the Sunmax collagen bone graft matrix serves as a bone void filler that naturally resorbs and facilitates new bone formation during recovery. The company's offerings extend to skincare products, such as Sunmax 12 jiao didi spray, Sunmax 11 collagen moisturizing cream, and a general collagen skincare line, all designed for post-dermal filler treatment aftercare.
www.sunmaxbiotech.comNo one on the platform currently holds 4728.TWO.
No tracked institution reports a position in 4728.TWO as of their last filing.
No one on the platform has traded 4728.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4728.TWOSunmax Biotechnology Co., Ltd. | $392.00 | -0.76% | $21.3B | — |
| 4105.TWOTTY Biopharm Company Limited | $78.60 | +0.38% | $19.5B | — |
| 4147.TWOTaiMed Biologics Inc. | $60.80 | +2.01% | $16.5B | — |
| 6491.TWPegavision Corp. | $393.00 | +0.77% | $30.2B | — |
| 6541.TWTanvex BioPharma, Inc. | $30.55 | +0.83% | $8.1B | — |
| 6589.TWOEirGenix Inc. | $45.95 | -2.34% | $13.7B | — |
| 6620.TWOHanda Pharmaceuticals, Inc. | $134.00 | +9.84% | $22.3B | — |
Source: Financial Modeling Prep · peers by sector/industry